Sentence	Sentiment	Title	Url	Date
ZURICH Switzerlands Molecular Partners which is hoping to produce an antiviral drug against COVID19 said on Monday that it had completed initial manufacturing runs for its candidate MP0420 that it aims to test in humans starting in November	Positive	ZURICH Switzerlands Molecular Partners which is hoping to produce an antiviral drug against COVID19 said on Monday that it had completed initial manufacturing runs for its candidate MP0420 that it aims to test in humans starting in November	http://www.reuters.com/news/health/article/us-molecular-partners-covid/molecular-partners-completes-manufacturing-runs-in-bid-for-covid-19-drug-idUSKBN2650II	2020-09-14
Fresh off the failure of its eye drug abicipar in the United States Molecular Partners is seeking to rebound with the experimental drug called MP0420 against COVID19	Positive	ZURICH Molecular Partners is getting a payment in the high single digit of Swiss francs from the Swiss government to reserve doses of an earlystage drug candidate that the Zuricharea biotechnology company is developing for COVID19	http://www.reuters.com/news/health/article/us-molecular-partners-swiss/molecular-partners-gets-swiss-govt-payment-for-covid-candidate-idUSKCN2570HX	2020-08-11

Sentence

Sentiment

Title

Url

Date

ZURICH Switzerlands Molecular Partners which is hoping to produce an antiviral drug against COVID19 said on Monday that it had completed initial manufacturing runs for its candidate MP0420 that it aims to test in humans starting in November

Positive

http://www.reuters.com/news/health/article/us-molecular-partners-covid/molecular-partners-completes-manufacturing-runs-in-bid-for-covid-19-drug-idUSKBN2650II

2020-09-14

Fresh off the failure of its eye drug abicipar in the United States Molecular Partners is seeking to rebound with the experimental drug called MP0420 against COVID19

Positive

ZURICH Molecular Partners is getting a payment in the high single digit of Swiss francs from the Swiss government to reserve doses of an earlystage drug candidate that the Zuricharea biotechnology company is developing for COVID19

http://www.reuters.com/news/health/article/us-molecular-partners-swiss/molecular-partners-gets-swiss-govt-payment-for-covid-candidate-idUSKCN2570HX

2020-08-11